ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 01, 2024 21:00 ET
|
ProPhase Labs, Inc.
Garden City, NY, April 01, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biopharma, genomics, and diagnostics company, today announced...
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 23, 2024 17:10 ET
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., Feb. 23, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
Vislink Technologies, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 02, 2024 17:23 ET
|
Vislink Technologies, Inc.
Mt. Olive, NJ, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (“Vislink” or the “Company”) (Nasdaq: VISL) announced today that effective January 1, 2024, Bill Sweeney was granted a...
Vislink Technologies, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
July 07, 2023 16:30 ET
|
Vislink Technologies, Inc.
Mt. Olive, NJ, July 07, 2023 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (“Vislink” or the “Company”) (Nasdaq: VISL) announced today that on July 5, 2023, Steven Teese was granted a time-based...
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 05, 2023 15:08 ET
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., May 05, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 27, 2023 16:00 ET
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., April 27, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
July 21, 2022 18:00 ET
|
ProPhase Labs, Inc.
Garden City, NY, July 21, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced that it has granted an inducement stock option...